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Central Asia is perfectly placed for a mega HIV 
epidemic. Drugs are produced, trafficked, and used
throughout the region. People are impoverished and
the economy is in shambles. Governments are weak.
Compared to other countries in Central and Eastern
Europe and the former Soviet Union, the history of
communism in some parts of Central Asia left a
more scarring legacy of repression. Women are 
subordinated. And the first instinct of any conser-
vative culture seems to be to deny drug and sex
issues, even when they are a public health concern.
We know what doesn’t work. Seizing heroin
at the border and putting drug users in prison 
doesn’t stop HIV. And repressing the distribution of
health information, as Chinese authorities recently
did with AIDS activist Wan Yanhai, M.D., doesn’t 
stop AIDS. Wan was detained just outside the
Central Asian border for posting information about
the contaminated blood supply in Henan province
on the web. Wan had been selected in early July 
to be the first recipient of a joint award from 
Human Rights Watch and Canadian HIV/AIDS 
Legal Network International.
We know what works: harm reduction. Harm
reduction interventions have a heartening chance to
work in Central Asia because the epidemic is in 
the early stages. However, if harm reduction meth-
ods are going to be accepted in the region the 
climate must change. Governments must acknowl-
edge widespread drug use; recognize drug users 
are an integral part of society—not isolated and
expendable as many pretend; provide services for
drug users; and assure their access is not prevented
by legal repression or social stigma. When service
providers and governments embrace these changes
great things happen, as in Kyrgyzstan where people
can now get methadone and stabilize their lives.
We dedicate this issue of Harm Reduction
News to Central Asia and the complexities of its HIV
epidemic. Several articles lay out the problems.
The correlation between drug availability and 
trafficking with drug use and HIV is conclusively
demonstrated by Chris Beyrer and his research.
Jay Dobkin talks about the challenges of treating 
HIV patients in Central Asia. And all of the human
rights fault lines, from international treaties to 
the right to exchange a needle with-
out fear, are described in articles by
Erika Dailey and Joanne Csete.
The projects are the solution.
Turkmenistan now offers harm reduc-
tion information and condoms to 
prisoners, one of the most vulnerable
populations. Another vulnerable pop-
ulation, commercial sex workers,
benefits from services in Uzbekistan.
The youth of Central Asia are being
trained to talk to disaffected street
youth who are in danger of getting HIV. Given 
an opportunity through study tours to see harm
reduction working, even police will come around 
to accept it. Tajikistan is trying to reach out to 
ever more drug users with its needle exchange 
projects, and Kyrgyzstan will soon evaluate the 
success of its pilot methadone projects, the first in
Central Asia. And in an effort to better meet the
HIV prevention needs of the region, a joint project
of the U.S. Agency for International Development
and the Open Society Institute is rapidly increasing
the number of such projects in the region.
The devastation of Central Asia by HIV is not
inevitable, but we must act quickly to change old,
destructive patterns of behavior and clear the way
for effective prevention.
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HIV Looming in Central Asia
by Kasia Malinowska-Sempruch
Newsletter Focus
The devastation of Central Asia by
HIV is not inevitable, but we must act
quickly to change old, destructive
patterns of behavior and clear the
way for effective prevention.
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Harm Reduction News
The International Harm Reduction Development program (IHRD) supports local, national, and regional initiatives in Central and Eastern Europe, the RussianFederation, and Central Asia that address drug problems through innovative
measures based on the philosophy of harm reduction. Harm reduction is a pragmatic and
humanistic approach to diminishing the individual and social harms associated with drug
use—especially the risk of HIV infection. The approach places an emphasis on human
rights, common sense, and public health. In practice, harm reduction encompasses a wide
range of drug user services including needle and syringe exchange, methadone treatment,
health education, medical referrals, and support services.
IHRD Mission & Core Activities
Providing grants and technical 
support to local direct service
providers. IHRD supports over 180
harm reduction projects in more than
twenty countries of Eastern Europe and
the former Soviet Union. While all 
interventions are tailored to local condi-
tions and client needs, the majority of
projects include a needle exchange 
component. Making clean needles avail-
able to injection drug users has proven
effective as an HIV prevention strategy.
Supporting regional, population-
based, and topic-specific initiatives.
IHRD supports regional conferences,
trainings, and projects on issues such 
as street kids, HIV prevention in prisons,
ethnic minorities (such as Roma com-
munities), methadone treatment, and 
commercial sex workers.
Promoting local and regional capac-
ity-building. IHRD builds capacity by
funding and organizing trainings, work-
shops, and conferences for a variety of
harm reduction stakeholders including
NGO staff, government officials, policy 
officers, prison workers, and health 
care providers.
Creating an enabling public policy
atmosphere. IHRD works to influence
national-level drug policies and practices
by sponsoring advocacy efforts, research,
conferences, and decision-maker study
tours.
IHRD is part of OSI’s Network 
Public Health Programs and works
in close cooperation with the local
Soros Foundation Network and the
Drug Policy Alliance.
THE OPEN SOCIETY INSTITUTE is a private operating and grant-making founda-
tion that seeks to promote the development and maintenance of open societies around the
world by supporting a range of programs in the areas of educational, social, and legal reform,
and by encouraging alternative approaches to complex and often controversial issues.
The Open Society Institute is part of the Soros foundation network, an informal network 
of organizations created by George Soros that operate in over 50 countries around 
the world, principally in Central and Eastern Europe and the former Soviet Union, as well as
in Guatemala, Haiti, Mongolia, Southern Africa, and the United States.
IHRD reduces drug related harm by:
OSI Mission 
by Jennifer Adams and Valeria Gourevich
The growth of HIV in Central Asia is related 
to the serious socio-economic, political, and
psychological problems prevalent in the region
since independence in 1991. The dramatic
increase in narcotics trafficking from Afghanistan
through the region has accelerated drug 
use and concomitant HIV infection. Areas
renowned in the past for their beauty and 
utility, such as the “road of life” from Osh to
Khorog, which 25 years ago allowed for 
the transportation of food and other goods 
to the remote Pamirs, is now called “the road 
of death.”
Poor legislative control, breaches in border
and customs regulations, and widespread 
corruption among officials create a favorable
environment for narcotics trafficking. In turn,
the Central Asian countries through which
drugs are transported on their way to more
lucrative markets find a rapidly growing 
pop-ulation of at-risk groups. As the pace of
HIV transmission increases in Central Asia, a
pattern similar to some of the worst affected
countries in the world is developing.
The Centers for Disease Control and
Prevention, USA, has constructed simple 
projections for HIV trends in Central Asia.
They estimate that without immediate, wide-
spread, and effective prevention strategies,
the HIV/AIDS infection rate may reach 3 
percent by the end of 2005. HIV infections
increased by 7 percent in Kazakhstan during 
the first five months of 2002, implying that by
2005 450,000 people could be infected 
with HIV.
Central Asia has a window of opportunity
to contain the current relatively low rate of 
HIV transmission. But ineffective and limited
prevention measures that are aimed at punish-
ing those with HIV, chiefly injection drug users
(IDUs), may prematurely shut that window.
Earlier this year, the Open Society Institute
(OSI) and the Central Asia Regional Mission of
the U.S. Agency for International Development
(USAID) launched a joint prevention program
that aims to cover the five Central Asian 
countries with effective HIV prevention inter-
ventions. A secretariat established under the
umbrella of the Soros Foundation in Kazakhstan
coordinates the activities. The OSI-USAID par-
tnership is unique, as it also includes the Soros
Foundation of Kazakhstan, the national Soros
Foundations of Kyrgyzstan, Uzbekistan, and
Tajikistan, and the United Nations Development
Program representative in Turkmenistan.
The joint effort is already scaling up 
effective HIV prevention interventions among
groups at risk—IDUs, commercial sex workers
(CSWs), and prisoners. Before the partnership,
OSI had implemented 18 harm reduction 
projects in Central Asia and now, with support
from USAID and other partners, the total 
number of interventions should reach 34-38 by
the end of 2003.
In Kazakhstan, sites were carefully selected
for new programs in Astana, Pavlodar,
Shimkent, and Temirtau. Astana is Kazakhstan’s
new capitol, where migration has caused a
sharp increase in IDUs. In Temirtau, the epi-
center of the Central Asian epidemic, the 
project will reach more than 1,000 IDUs and
involve those already infected with HIV.
In Pavlodar, a model site serving IDUs and
CSWs will be developed. In Shimkent, located
on the main drug trafficking route on the 
border with Uzbekistan, the number of CSWs
who stand “on duty” near the highway will 
be the focus of a new project. In Tajikistan, the
main transit point for drugs through Central
Asia, four new projects will complement the
two existing needle exchange programs. The
experiences and lessons learned from work in
these countries will inform the activities
planned for Uzbekistan and Turkmenistan,
where seven more projects will be launched
this year, including pioneering work in prisons.
Central Asia needs the development of 
HIV prevention programs that promote open
society principles and address the needs of vul-
nerable groups. These programs can help prop
open the window of opportunity and maintain
hope for controlling HIV infection in the region.
Jennifer Adams is the director of the Office of
Social Transition, USAID Regional Office for
Central Asia.Valeria Gourevich is the director
of the Secretariat of the Joint USAID-
Soros Network Project, HIV Prevention 
in Central Asia.
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A Window of Opportunity to Control HIV
Expanding Capacity
Map of the Joint USAID-Soros Network Project, HIV Prevention in Central Asia.
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The mechanisms that turn poppy cultivation into HIV outbreaks are just
beginning to be understood, as is the special vulnerability of individuals
and communities in trafficking zones. The main heroin producers for 
the Golden Triangle are Burma and Laos. For the Golden Crescent,
Afghanistan and Pakistan. Currently, these states are thought to account
for 80 to 90 percent of the world’s heroin supply. In the Golden Triangle,
the spread of HIV has been well documented in Burma,Thailand, China,
India, Malaysia, Vietnam, and, more recently, Indonesia. For the Golden
Crescent, where we have much less data and where the HIV epidemics
are newer, the spread of HIV and/or hepatitis C appears to be underway
in Pakistan, India, Iran, Tajikistan, Uzbekistan, Russia, Ukraine, Belarus, and
several states in Eastern Europe.
Most studies in these regions investigating the spread of HIV in
injection drug users (IDUs) have found that hepatitis C (HCV) infection
is more common and may indicate vulnerability to future HIV spread.
HCV prevalence among IDUs generally reaches 90 percent prevalence 
or higher soon after the introduction of the virus into IDU networks —
a function of the very high transmissibility of the virus through injection.
Legal opium poppy cultivation for production of pharmaceutical
drugs like morphine, codeine, and Demerol, is centered in Tasmania,
Australia, India, and Turkey, and has not been associated with heroin 
production, trafficking, or the spread of blood borne infections.
The links between heroin and HIV spread are due to the illicit nature 
of criminal production and distribution, increasing numbers of young users
injecting with unsafe equipment, and a lack of HIV prevention services 
for drug users.
HIV Spread and Injection Drug Use
In 2000, our international team published the findings of investigations 
that used molecular epidemiology, satellite technology, qualitative research
methods, and epidemiologic reviews of HIV infections along four heroin
trafficking routes out of Burma and Laos and into China, India, Vietnam,
and Thailand. Using DNA fingerprinting technology, we were able to show
that HIV viruses from the blood of infected IDUs could help trace 
heroin routes. Further, heroin users and petty traders helped us to 
understand how heroin use spreads in communities and pointed to key
roads, villages, towns, and cities through which Golden Triangle heroin 
was moving and leaving legacies of addiction and AIDS. Since our findings
were published other groups have independently investigated these
zones, confirming our findings and, sadly, documenting further spread 
and worsening health in communities in China,Vietnam, and Burma.
Likewise, the Crescent destination markets of Russia, Ukraine,
Belarus, Kazakhstan, Pakistan, and Iran are all experiencing heroin use 
outbreaks among their young people, and all now appear to have HIV
outbreaks or emerging epidemics related to this use. Heroin exports
from Afghanistan and Pakistan are at the root of these complex new
problems. The challenges are regional but point to a global problem 
which ties the Crescent to the Triangle: illicit heroin revenues.
On paper, Afghanistan was the world’s poorest state in 2000,
while Burma was one of the United Nations’ “least developed”
countries. Afghanistan is almost entirely dependent on donor aid in 2002
and has essentially no foreign reserves, a bankrupt treasury, and 
limited licit exports. We do not know the details of the economics of 
the trafficking networks based in the Golden Crescent, but we do know
that taxes on poppy farmers and protection money from traf-
fickers were among the main sources of revenue for both the Taliban 
and the Northern Alliance before the current regime came to 
power. In both Burma and Afghanistan, heroin has allowed for 
black market weaponspurchases to fund militias, insurgencies, and 
crime. Afghanistan has the potential to grow other crops, including 
grain and orchard production, but these require irrigation systems,
which have largely been destroyed, and access to markets, which remains
a huge challenge for much of the country.
Reducing the opium supply from these regions will require estab-
lishing viable alternative economies for the rural poor, which will take
time, sustained donor investment, and stable functioning civil societies.
Intertwined Epidemics
HIV Infection and Heroin Trafficking
by Chris Beyrer
T
he complex relationship between the epidemic spread of HIV and heroin trafficking is 
becoming increasingly clear. This emerging pattern can be seen along trafficking routes from
the two primary illicit opium poppy growing and heroin manufacturing regions of the world:
the Golden Triangle of Southeast Asia and the Golden Crescent of Central Asia. The data on the 
relationship between heroin trafficking and HIV are compelling. But at least two crucial questions 
still stand. Why have societies from Ukraine to Vietnam been so vulnerable to these interactions? 
And what can be done to reduce the growing harm?
5Should Afghanistan descend again into civil strife and warlordism, heroin
production will likely rise again. Indeed, as in Burma, it is in the interest of
the narcotics cartels and the corrupt leaders they have often supported
that civil society fail—a chilling reality given the wealth, power, and
weapons that heroin revenues have already generated.
Another interaction may have special impact on both narcotics and
HIV spread, though the data are limited. Along at least some of the 
major trafficking routes, overland trucking routes have led to the 
development of services for truckers. In addition to fuel, food, and 
lodging, these often include sex services. In Southeast Asia these sex 
services are generally roadside brothels, karaoke parlors, and bars. In
Central Asia they may be less apparent and less understood but they are
still available. In some settings sex services may have young male sex
workers, as in the Pakistani trucking industry. These border zone sex 
service venues can overlap with drug trafficking and provide another
mechanism for the spread of HIV. On the Burma-Thai and Burma-
China borders, women and girls are trafficked on the same routes and 
by some of the same trafficking networks as heroin.
Policy Responses
Why have outbreaks of injection drug use associated with heroin traf-
ficking proven so difficult to prevent or control? In the major production
zones and their affected regions, treatment and prevention programs 
for drug users have been limited. In all of Asia the only place where 
heroin treatment and methadone maintenance are available on demand
is in Hong Kong. This is tragic, given that there is clear and growing 
international evidence of harm reduction’s success in preventing HIV
infection and other blood-borne diseases among IDUs.
It is difficult to imagine public health tools with reasonable 
evidence of efficacy which have generated as much debate and remained
as underused as HIV prevention programs for IDUs. A review of the 
literature suggests three principal problems with the implementation of
harm reduction. First, it is repeatedly seen as condoning or facilitating
injection drug use, making it politically unpopular. Second, it has faced 
legal, security, and policy challenges since it requires “safe” domains of
interaction with active IDUs, a special concern in trafficking zones 
where criminal control may be extensive. And third, in order to effective-
ly reach the IDU populations and stop the HIV epidemic, many more 
needle exchange programs must be available and used by IDUs.
Conclusions
Individuals, communities, and countries located on major heroin trafficking
routes face multiple epidemics in 2002: heroin use, heroin injection,
and the HIV infection that follows. While a clear long-term goal for 
these states is to be free of drug trafficking, the realities of the current
political and development situations of the major producers, notably
Burma and Afghanistan, suggest that narcotics-based economies will 
be with the world for some time. The health impacts of heroin 
trafficking could be minimized by a public health approach that includes
reducing heroin addiction through improved treatment and support 
continued on page 6
Tajikistan authorities burn bags of seized heroin and opium. Photo © 2002 Hans-Jürgen Burkard
Legal opium poppy cultivation for production of pharmaceutical drugs
has not been associated with heroin production, trafficking, or the spread of blood 
borne infections. Illicit criminal production and distribution has.
continued from page 5
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for IDUs and reducing HIV spread through expanding harm reduction 
and needle exchange programs. Preventing the spread of HIV beyond
IDUs may be critically important to the prevention of wider epidemics 
of HIV/AIDS.
A clear priority for further research and programs are the frontline
Central Asian states in the Golden Crescent. These must be considered
high risk states for the explosive spread of HIV in the coming years,
and could benefit from the programmatic experience and research exam-
ining the heroin and HIV interactions of the Golden Triangle.
Chris Beyrer, MD, MPH, is the director of the Johns Hopkins Fogarty
AIDS and TB International Training and Research Programs at the Johns
Hopkins University Bloomberg School of Public Health in Baltimore,
Maryland, USA.
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It is difficult to imagine proven, 
effective public health tools which have 
generated as much debate andremained 
as underused as HIV prevention 
programs for IDUs.
Molecular work in Central Asia is urgently needed to understand
what viruses are spreading there and to help understand the movement 
of heroin in the region. This work is underway in a few states, and data may
be available in the next year. HIV subtypes, in addition to their use in 
tracking spread, may have important implications for HIV vaccine research,
and so this is not simply an academic question, but a public health one.
Molecular subtyping of HIV-1 strains has helped us to understand HIV
spread in many settings. HIV-1 has numerous subtypes based on genetic 
differences, and are labeled HIV-1 subtype A, B, C, and so forth to K.There
are also a number of new recombinant subtypes, generally named 
after their parent strains, such as the B/C recombinant found in China.
In the trafficking zones around Burma subtypes B, C, E, and two different
B/C recombinants have been found, and the patterns of their spread have
helped describe both HIV dynamics and heroin trafficking.
In Central Asia virtually no subtyping data is available. So we do not know
what HIV strains, if any, are circulating among IDUs in Afghanistan itself,
Pakistan, Iran, or the republics.
Subtyping HIV Strains
Photo © 2002 Hans-Jürgen Burkard
7Marat is 14 years old and lives in a crumbl-
ing apartment complex built in the 1960s
for workers at a now derelict shoe factory
in Temirtau, Kazakhstan. His father is unem-
ployed, depressed, and away from home 
for days at a time. His mother works for 
the city shoveling snow in the winter and
sweeping streets in the summer. Openly
shooting heroin in the toilets and sniffing 
solvents to ward off hunger, Marat’s 
schoolmates go through the motions of
studying in their overcrowded and under-
heated classes. Marat, who tries to make
money from stolen windshield wiper 
blades, has been beaten up by police,
offered money for sex by a local truck 
driver, and spends the little he earns to buy
food for his sisters and cheap vodka to 
dull the pain of his nowhere life.
Marat is part of a swiftly growing 
population of street-involved youth in
Central Asia. He is not yet homeless 
nor ready to abandon school entirely, but 
his life revolves more around making money
and getting high than spending time in
school or at his barely functioning neigh-
borhood recreation center. He is at high 
risk for drug abuse and HIV, and is seen as 
a public nuisance and potential threat.
Young people like Marat need to 
discuss decisions about the risks they face
with compassionate listeners. The best 
people to reach out to such youth are 
youth themselves.
Street Kids International (SKI) is work-
ing to bolster the skills of youth workers 
in Central Asia. Its first series of pilot Street Choices workshops for 
youth serving professionals in Kazakhstan, Kyrgyzstan, and Tajikistan was in
1999 and focused on drug use and HIV prevention. Local groups had
grown tired of hosting international “experts” who advised them on how
to transform their professional practice. By contrast, SKI brought the
approach it developed with partners in South East Asia, Latin America,
and Southern Africa that taps into local knowledge and approaches 
while also introducing new tools from colleagues in other countries.
The fundamental principles of SKI’s workshop are share, explore,
practice, and contribute. Best practices are shared; local conditions are
explored; the integration of new tools with
existing materials and methodologies is 
practiced; and local groups contribute their
knowledge back to SKI’s global program.
The workshop itself reflects an open, res-
ponsive approach that SKI and its partners
believe is best for street involved youth. Too
often, youth are lectured at by “experts” who
make little effort to understand the complex 
environments in which they live.
Central Asian workshop participants
concluded that programs for street-involved
youth need to go beyond providing informa-
tion and warnings about the risk of drug 
use, needle sharing, or unprotected sex to
develop young people’s decision-making and
health-promotion skills. They must meet
street-involved youth on their own terms—
without lectures, moralizing, or prescriptive
solutions—and focus on harm reduction,
self-care strategies, and genuine alternatives.
Outreach workers must be equipped with
holistic tools and methodologies to build
open-ended relationships with marginalized
youth, many of whom distrust the advice and
guidance of adults on any subject, let alone
drugs and sex.
Capacity building work in Central Asia 
is now in the hands of local training partners
who are supported by the Almaty-based
Community Development Center Accord.
This summer, a team from Kazakhstan,
Tajikistan, and Kyrgyzstan developed new
materials, including a book and video with
guidelines for workshop activities. Teachers
and guidance counselors in the region who
work with youth such as Marat in marginal urban schools will now 
have this as a training tool. An example of what grows out of sharing,
exploring, and practicing, this is another welcome contribution to future
Street Choices workshops in the former Soviet Union and throughout 
the world.
David James-Wilson is the director of program development for Street
Kids International in Toronto, Canada. Lena Vinogradova is the director
of the Community Development Center Accord in Almaty, Kazakhstan
and a regional program advisor for SKI in Central Asia.
Youth programs 
must meet street youth 
on their own terms—without
lectures, moralizing, 
or prescriptive solutions.
Local Solutions
Street Youth Get Help from Peers
by David James-Wilson with Lena Vinogradova
Photo © 2002 OSI-Kazakhstan
Is access to harm reduction services a funda-
mental human right?
The dilemma of a woman drug user in
Central Asia provides one answer. She wants 
to take advantage of a needle exchange site,
but is afraid that if she uses the site, her name
will be entered on a government list and she
will risk official harassment and perhaps even
arbitrary arrest. For her, using needle exchange
is as much a struggle for the right to privacy, the
right to be free of police violence and other
official abuse, and the right not to be arrested
or detained arbitrarily as it is a struggle for 
the right to basic health care and protection
against a deadly disease. If she has children,
it may also be a battle to protect the rights 
of her children to be free of stigma and 
discrimination and not to be institutionalized
against her will.
For a young man injecting drugs and 
living on the streets in an urban center of
Eastern Europe, the struggle for clean needles
or methadone may also be the struggle not to
be harassed by the police, arbitrarily rounded
up on the street like a criminal, or put in condi-
tions of detention where needle-sharing and
lack of protection from sexual violence make
HIV transmission almost inevitable.
Harm reduction in the former Soviet
empire would be much easier if governments 
in the region respected the commitments 
contained in the human rights treaties they 
have already ratified, especially the International
Covenant on Civil and Political Rights, which
guarantees due process and protects all 
persons from discriminatory or arbitrary arrest
or violence. Instead, governments have let the
social stigma attached to drug use—and 
the politics of disdain and neglect that follows
stigma—override those commitments.
Whether it be the daily struggles of 
ordinary people to use harm reduction servic-
es with dignity and free of fear, or the lofty 
sentiments of international treaties, one thing 
is clear : the provision of harm reduction is a
global human rights issue.
The continued, widespread abuse of the
human rights of injection drug users (IDUs) is 
a recipe for a bigger HIV/AIDS epidemic in
Eastern Europe and Central Asia. People who
face harassment, stigmatization, and official
abuse are the least likely to seek information
and services related to HIV. Stigmatizing and
marginalizing the highest-risk persons with
respect to AIDS is a surefire boost for the 
epidemic as it pushes those most in need 
of protection and prevention underground.
In Africa, AIDS feeds off of the subordinate 
status of women and girls who cannot nego-
tiate safe sex. In many parts of Asia, it has
gained a foothold because of the ostracization
or persecution of women in prostitution 
and men who have sex with men. HIV/AIDS,
too, is a global human rights challenge.
Protecting the rights of and reducing dis-
crimination against IDUs, men who have sex
with men, and others who have been heavily
affected by HIV, is good public health policy and
a good human rights priority. But action to 
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Calling for an Alliance
continued on page 10
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Human Rights and Harm Reduction
9The first time Kyrgyzstan’s health care and law enforcement repre-
sentatives discussed methadone substitution therapy in the summer 
of 2000, they were decidedly unenthusiastic. The new idea met with 
prejudice and stagnant thinking.
So how, only two years later, did Kyrgyzstan become the first 
country in Central Asia to introduce the practical use of methadone 
for substitution treatment of opiate addiction? 
Unfortunately, this welcome policy change was helped by the reve-
lation in the fall of 2000 of a sharp increase in the number of HIV cases 
in the Osh region. The increase was especially high among injection 
drug users (IDUs). For the first time many people were forced to seriously
consider HIV/AIDS prevention.
Kyrgyzstan also had favorable drug laws prior to the introduction of
methadone treatment. There are no legal barriers to the use of narcotic
drugs to treat drug addiction. Buprenorphine, for example, had been 
used under the name of norphine for many years for the detoxification 
of opiate addicts. Further, methadone was not included on the list of 
narcotics prohibited from use for medical and scientific purposes.
Implementing methadone therapy in Kyrgyzstan had distinct legal,
technical, and practical stages.
During the legal stage, advocates for methadone treatment had 
to overcome opposition from the government ministries responsible 
for public order and control of narcotic drugs. We had three private 
working meetings with them dedicated to the methadone program.
We also had three televised public discussions involving doctors,
lawyers, and police. And we held briefings for the mass media that 
provoked many newspaper articles in the months leading up to the launch
of the methadone program.
By the summer of 2001 the Soros Foundation–Kyrgyzstan and 
the Republican Narcology Center had received all the necessary paper-
work, clearing the way for an agreement that provided a grant to the 
center for a pilot methadone therapy project in Bishkek.
Once all the legal requirements were cleared, the technical stage
began.We made minor repairs to the center, bought essential equipment,
and signed an agreement for the delivery of methadone hydrochloride
from Slovakia.
In late January 2002, methadone arrived in Bishkek. “This is a 
historic event,” said IHRD’s methadone technical advisor Emilis Subata
from the Vilnius Substance Abuse Treatment Center in Lithuania.
“Methadone has finally appeared in Central Asia.”
Implementation of the third, practical stage started in April in
Bishkek and Osh when the projects saw their very first clients, who 
had heard about the project from the media.The majority of later clients
came to the projects based on the recommendation of participants.
In a strategic compromise move to appease opponents concerned
about the illegal circulation of methadone, the programs have a high
threshold for accessibility. Methadone therapy can be provided only 
at state narcological institutions, and doctors from other agencies or 
with other specializations do not have the right to prescribe methadone
to their patients. Anonymous participation in these programs is prohib-
ited. The methadone solution is given out daily and there is periodic 
testing of clients for the presence of other narcotic drugs and psychotrop-
ic substances. If the consumption of illegal opiates is confirmed the 
participant can be excluded from the program. We expect these harsh
conditions to be softened, however, if the pilot projects prove successful.
Currently there are 72 participants in the two programs—
42 in Bishkek and 30 in Osh. It is informative to profile the Bishkek 
It is too early to speak about conclusive
results for Central Asia’s first methadone 
pilot, but the changes so far have been 
almost entirely positive. 
Kyrgyzstan: Leading the Way on Methadone
by Tynchtykbek Asanov
continued on page 10
Elvira Muratalieva (left) of Soros Foundation Kyrgyzstan with Tynchtykbek Asanov (right) and
staff of the Bishkekmethadone program. Photo by Matt Curtis
In July Kazakhstan legalized the use of methadone as a drug replacement
therapy, making it the second Central Asian country to do so, and one of
an increasing number of former Soviet countries to adopt or consider
methadone in the last year. Two pilot programs were approved, and are
scheduled to begin operation in late 2002 in Pavlodar and Karaganda with
approximately 80 patients.
Ukraine is now looking to oblast narcology centers to pilot methadone
replacement therapy after two years of policy work.
Two pilot projects in Belarus will likely be funded by UNDP-Belarus and
IHRD before the end of 2002.
IHRD will provide technical assistance to a World Bank funded methadone
project in Moldova later this year.
IHRD and Continuum Health Partners, Inc. are sending top narcologists
from Russia on a methadone study tour to Paris this fall.
Methadone News
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support such measures remains hard to find in
too many countries.
Mainstream human rights organizations
have been slow to embrace harm reduction
and the cause of reducing HIV/AIDS-related
rights abuses. Civil society groups that focus on
harm reduction and HIV/AIDS should do what
they can to draw human rights groups into their
struggle, and human rights groups should realize
that IDUs and people affected by HIV/AIDS 
can help lead the way in human rights battles.
Abusive authorities will always go after IDUs
and AIDS-affected persons, along with racial
and ethnic minorities, because it is easiest to get
away with mistreating those in society who are
most stigmatized. If abuses can be reduced
among these populations, including by their
empowerment to speak out and organize on
their own behalf, the overall human rights gains
will be significant.
Does framing these issues as a human
rights struggle really help? HIV/AIDS non-
governmental organizations from the North
and South have joined in the last two years 
to form an effective coalition promoting 
the right of all persons living with AIDS to 
treatment for their disease. In this period,
thanks to long advocacy, the United Nations
Commission on Human Rights twice asserted
that persons with AIDS have the right to anti-
retroviral treatment, once over the abstention
of the United States. These resolutions helped
create an environment in which African, Asian,
and Latin American governments gained 
confidence to strike deals with manufacturers
of cheaper generic drugs and otherwise 
challenged the multinational pharmaceutical
companies that had a lock on many markets.
It is time for national and international
human rights groups, including international
groups and the growing civil society movement
for human rights in the former Soviet states,
to challenge repressive drug laws and official
practices that violate international human rights
standards. It is time for them to join the harm
reduction and HIV/AIDS movements in making
a well informed and deafening noise about the
crime of abusing the human rights of IDUs.
Joanne Csete is the director of the HIV/AIDS
and Human Rights Program at Human Rights
Watch in New York.
Governments have let the social stigma attached to drug us—and the 
politics of disdain and neglect that follows stigma—override human rights commitments.
Human Rights continued from page 8
Kyrgyzstan continued from page 9
Photo © 2002 Hans-Jürgen Burkard
participants.They range from 20 to 51 years old. One-quarter of them are
women. They have been using opiates for an average of 11 years and 
practically all of them have concomitant disorders such as anxiety and
depression. A little more than half are infected with viral hepatitis.
At the time they entered the program, almost all of the participants 
used heroine intravenously (one was shooting up in the muscle tissue 
as all accessible veins had atrophied or sclerosed). The average dose 
of heroine during the last month before entering the program was 1.2
grams a day in 2-3 daily injections. Two of the program participants 
are HIV positive. Nearly 60 percent have prior convictions.
Since the project started, three participants have left. One was 
convicted for a criminal offence, another was excluded from the 
program for an attempt to carry out methadone from the office, and 
the third stopped coming into the program of his own accord.
The somatic health of the participants has improved noticeably.
The patients and their relatives report sleep stabilization, restoration,
and “mood improvement.” Women also report restoration of their 
menstrual cycles.
While there have been no major changes in the social status of 
the participants since the projects started, one patient has gotten married,
one has returned to his family, and two participants have started working.
There has also been a significant improvement in personal relationships,
especially with the clients’ families.
It is too early to speak about conclusive results, but the changes 
that have occurred have been almost entirely positive. We plan to 
conduct a program evaluation next year and present its results to all 
countries in Central Asia.
Tynchtykbek Asanov is the director of the Republican Narcology 
Center and chief narcologist at the Ministry of Health in Kyrgyzstan.
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In the last year and a half the number of people
infected with HIV in Tajikistan increased eight
times more than it did in the last decade.
Seventy-three percent are injection drug users
(IDUs).As stunning as these figures are, they do
not come close to the reality of the HIV 
epidemic. As in other Central Asian countries,
the lack of tests and diagnostic equipment
makes epidemiological surveillance of the 
vulnerable populations almost impossible.
We do know, however, from a joint gov-
ernment-UNAIDS rapid situation assessment
of drug use in Dushanbe in 1999, that the
spread of HIV is related to injection drug use.
An estimated 15-18 thousand people were
found to be users of drugs, mainly heroin, of
which 4-5 thousand injected. Almost no drug
users used condoms.
The assessment also determined that 
the violent increase in the number of IDUs in 
the previous few years among 20-35 year olds 
was related to the economical high from 
injecting rather than inhaling heroin. Sharing
syringes in a group was typical among 93 
percent of the IDUs and few drug users disin-
fected their apparatus.
The rise in drug use can be squarely
blamed on the appearance of heroin in the
country. Before 1996-1997 there were practi-
cally no IDUs. Bordering Afghanistan, China,
Uzbekistan, and Kyrgyzstan, Tajikistan has the 
misfortune of being located on a drug traffick-
ing route. Both the fall of the Soviet Union in
1992 and the civil war in 1993-1994 made it 
difficult to control the flow of drugs. Further,
in the four years after the end of Soviet rule,
unemployment increased seven times. Many
people looked to drug smuggling and dealing 
to earn money.
Recognizing the growing HIV problem,
the Republican AIDS Center opened two sta-
tions for IDUs in Tajikistan’s capital, Dushanbe, in
November 1999.With support from UNAIDS,
the Ministry of Health, and the city government,
we provided counseling, disseminated infor-
mation, distributed condoms, and exchanged
needles. The program was well run and only 
specially trained consultants (a narcologist,
a dermatologist-venerealogist, and a psy-
chotherapist), social workers, and volunteers
worked in the stations. Everything was anony-
mous and confidential. Yet during the first six
months we reached only 60-70 people.
To attract more clients to the projects,
the Republican AIDS Center worked with
trained volunteers to do outreach and peer
education among drug users. It was also neces-
sary to create a more favorable environment
for the harm reduction program and stimulate
public debate. We held seminars, round table
discussions, and press conferences for politi-
cians, law enforcement officials, the mass media,
and the general population on HIV prevention
among IDUs.
Six new stations were opened in 2000
with financial support from the Open Society
Institute in New York.The worsening HIV situa-
tion prompted the creation of several more
locally funded programs across the country. All
told, 15 stations now serve an average of 1,500
drug users daily, approximately 5 percent of the
estimated number of IDUs in the country.
Key ministries and departments have
already approved a national strategic plan to
respond to HIV/AIDS. The plan, developed by
the government, nongovernmental organiza-
tions, and international experts, highlights HIV
prevention among IDUs.The problem is recog-
nized at the highest government levels, including
by Tajikistan’s vice-prime minister who spoke
out about HIV prevention among IDUs at the
International AIDS Conference in Barcelona in
July. Recognition has been translated into 
financial support—the government funds eight
projects—but the need is far greater than the
state’s ability to meet it.
Muratboki Bekhazarov is the director of the
Republican AIDS Center and National AIDS
Coordinator.
The rise in drug use can be squarely blamed on the
appearance of heroin in the country. Before 1996-1997
there were practically no IDUs.
by Muratboki Bekhazarov
Tajikistan
Tajikistan near the Afghanistan border, Russian border guards apprehend two young men.
A bag of heroin is in the foreground. Photo © 2002 Hans-Jürgen Burkard.
Struck by Drugs, HIV, and a Will to Respond
First, they check through our things and our clothes at the train station and
ask rudely, “Where are you hiding the narcotics?”… Last time… they found
50 grams of heroin on someone in our car, so they held the train for four 
hours. They took all the passengers in that car out to the station building,
separated the men and the women and made us all strip naked … It’s 
appropriate that they arrested the guy who had the heroin on him,
but why do they humiliate and insult everyone else? Khomid Irodai, in 
the newspaper Sadoi Mardum,Tajikistan, 2000.
Two of the greatest risks to human development in Central Asia 
are the spread of AIDS and human rights violations. While they appear 
to be very different phenomena, a careful examination of the human
rights environment existing in the region offers clues to both the reasons
for the disease’s rapid spread and the most effective ways to combat it.
While official prevalence rates are still low relative to population,
it is a stark but now indisputable reality that pre-conditions for an AIDS
explosion exist for the approximately 55 million residents of the five
Central Asian states: Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, and
Uzbekistan. HIV is spreading faster in this region than elsewhere 
in the world for one reason: drug use. According to UNAIDS data for
2001, injection drug use accounted for 70 percent of HIV transmissions 
in Kazakhstan. (The rate is 22 percent and 18 percent in Kyrgyzstan 
and Uzbekistan, respectively, and no data are available for Tajikistan 
and Turkmenistan.) 
Central Asia’s geographic situation on the drug trafficking route
from Afghanistan—the world’s largest producer of opium—to Russia,
Ukraine, and points west means that heroin is readily available and 
inexpensive, in many places cheaper than vodka. A single contaminated
syringe becomes more lethal than a knife, potentially killing off tens 
of people in a day—many more than could be infected through sexual
transmission. Until injection drug use is made safe, and other exacerbat-
ing factors like sexually transmitted infections are brought under control,
the rampant Central Asian drug trade will continue to cause dispropor-
tionately high rates of HIV infection.
Against the backdrop of the rise of HIV in Central Asia, the Open
Society Institute’s Central Eurasia Project (CEP), which has a geographic
mandate for Central Asia, has forged a close partnership with IHRD.
Together, we have advocated with United Nations and U.S. govern-
ment agencies, local governments, intergovernmental organizations such
as the Organisation for Security and Cooperation in Europe (OSCE),
and international donors for human rights protections as a pre-
condition for stemming the HIV epidemic in Central Asia.
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The Rights Approach is the Right 
Approach to Harm Reduction in Central Asia
by Erika Dailey
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Human rights protection as a tool against HIV
Global experience has shown that protection of human rights is one 
of the most important pre-conditions for effectively combating AIDS.
Sponsors of the XIV International Conference on AIDS, held in 
Barcelona in July, called on affected countries to “generally refrain from
using criminal law to deal with conduct that carries the risk of 
HIV transmission.” But in Central Asia, criminal penalties are routinely
imposed unduly and without deterring illegal activities, such as drug 
trafficking, which appears to be on the rise.
Arguably the most fundamental category of human rights relevant
to the discussion of AIDS prevention and treatment in Central Asia 
is the right to adequate health care. The International Covenant on
Economic, Social and Cultural Rights enshrines “the right of everyone 
to enjoyment of the highest attainable standard of physical and mental
health.” (Article 12.1) Specifically, it obliges States Parties to the 
Covenant to take steps, among others, to achieve “[t]he prevention,
treatment and control of epidemic… diseases.” (12.2.c) 
Civil rights protections, such as freedom of information, freedom
from discrimination, and due process guarantees, are equally fundamental
to access to AIDS prevention and treatment. State censorship muffles 
or blocks information about the epidemic to varying degrees in the
region. An extreme case is Turkmenistan. There, strict one-man rule 
has kept the country in near total information black-out since the early
1990s. As a result, official prevalence data are presumed to minimize 
social problems and are believed to be serious underestimates.
According to a World Bank study, for example, U.N. agencies estimate 
that there are over 50,000 drug users in the country, which has an 
adult population of approximately 2.5 million—over eight times higher
than the state estimate.
International human rights law prohibits all forms of discrimination.
However, discrimination against drug users in Central Asia is wide-
spread and unchecked. It can also be deadly. Part of state prejudice 
against drug users is a deep-rooted legacy from the Soviet period.
The Soviet state labeled drug users “parasites,” imposed criminal penalties
on drug users, and forced health professionals to turn in drug users to 
law enforcement authorities or face reprisals.
Existing prejudices against drug users are reinforced today by the
current hostile criminal justice environment. Human Rights Watch has
documented a well-established pattern of police planting heroin on 
political and religious dissidents in Uzbekistan to fabricate criminal 
charges against them and discredit them. Drug-related offenses are 
even punishable by the death penalty in Tajikistan.
IHRD has also reported several known incidents of police harass-
ment of drug users. In Osh, Kyrgyzstan, police raided a needle exchange
center in an apparent attempt to more easily meet their quota of arrests.
The result was to drive users away from the centers, where they could
safely dispose used needles and receive clean ones, and back into private
homes and alleyways where the risk of infection is much higher.
Police and border guards in Central Asia are also known to violate
fundamental due process norms in drug-related searches. Travelers at 
border crossings and checkpoints in Tajikistan, for example, report 
routinely undergoing searches without probable cause. For women 
from Tajikistan, the strip searches and vaginal searches are particularly
traumatic, according to Martina Vandenberg of Human Rights Watch,
because sexual violence was widespread during the civil war that 
devastated Tajikistan in the 1990s.
Fighting back
Virtually none of the governments in Central Asia currently has the 
funds, medications, or expertise to diagnose and treat those who will 
fall ill to HIV and AIDS and many other public health problems.The full-
blown AIDS epidemic is a disaster they cannot afford to have.
It is axiomatic that money spent on prevention will be much more
effective than money spent on treatment. Local governments and inter-
national donors can avert some of the social, economic and human 
devastation the disease leaves in its wake by making HIV prevention a 
top national priority. Some of this will require funds; donors can help. But
much more requires no money at all—simply state protection of human
rights, such as freedom of information and freedom from discrimination.
A centerpiece of the CEP and IHRD’s joint advocacy is sponsorship
of an international conference, “Health Security in Central Asia: Drug 
Use, HIV and AIDS,” October 14-16, 2002, in Dushanbe, Tajikistan,
co-sponsored also by the Netherlands Ministry of Foreign Affairs. The 
purpose of the conference is to promote specific strategies for the 
harm reduction approach to combating AIDS and to improve protection
of relevant human rights in the region.
But this is only one small step along a very long road. Central 
Asian governments need to arm themselves with not only clean syringes
but an unshakeable, demonstrable, and sustained commitment to human
rights protections if the burgeoning outbreak in Central Asia is to be
made anything less than catastrophic.
Erika Dailey is a program officer at the Open Society Institute’s Central
Eurasia Project.
Central Asian governments need to arm 
themselves with not only clean syringes 
but an unshakeable commitment to human
rights protections to avert an 
outbreak of AIDS.
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by Tadjikhon Saidikramova
Some commercial sex workers (CSWs) in
Uzbekistan are as young as 17 years old,
although most are in their early 20s, and stay in
the profession for an average of two years.
Few are married and 20 percent have a child.
Thirty percent inject drugs. But their biggest
risk of HIV is from unprotected sex: At 
the client’s request, every third CSW does 
not use a condom.
HIV is spreading in Uzbekistan. As of 
July 2002, 1,393 HIV cases were officially regis-
tered in the country—1,230 men and 169
women. Over 80 percent of the infected 
are injection drug users (IDUs). Sexual 
transmission is not prevalent but government
and United Nations experts predict that 
the number of cases will increase in the 
coming years. This trend is accompanied by 
the increasing involvement of drug users in
commercial sex work.
The center Sabo opened in Tashkent
four years ago to help socially vulnerable
women create a brighter future for themselves.
In ancient Uzbek, sabo means “morning fresh-
ness” and calls to mind a bright future.
The center started with very small steps.
Doctors and teachers experienced in social
and educational work were among Sabo’s
founders. The center had no financial or 
material resources, but we had extensive life
experience and a desire to change society for
the better. At first staff worked with students,
housewives, girls, and those entering marriage.
Soon the center’s HIV/AIDS program began to
focus on female CSWs because they are
among the most at-risk and marginalized 
groups in Uzbek society.
Uzbek laws do not define prostitution,
and liability for engaging in commercial sex
work is not clearly established. But public 
opinion is clearly established, condemning
women for frivolity with men and blaming
them for prostitution. Their stigmatization
forces them into secrecy making them difficult
to reach and mistrustful even of the people
who try to help them.
In this climate, we understood that
women would come only if they trusted us.
The negative public attitude makes 
CSWs wary of openly discussing their 
problems. But many of them are unhappy 
and need support. They need medical,
psychological, and legal aid. Sabo accepts
CSWs for who they are. Our goal is solely 
to lower the behavioral risks. The first 
women who visited Sabo benefited from our
unequivocal support and helped bring more
CSWs to HIV/AIDS prevention trainings.
Last year, the center conducted a 
six-month needs assessment project to learn
more about our clients. The project 
identified the need for confidential services
from a gynecologist, dermatologist-venerolo-
gist, psychologist, lawyer, and immunologist,
which the center now provides for free.
The center also runs a hotline and distributes
informational materials, syringes, and condoms.
Some CSWs train to become volunteers
themselves. And the center provides over 
90 CSWs with information about safety and
legal rights.
The CSWs that come to Sabo know
about safer sex, contraceptives, and the 
prevention of HIV and sexually transmitted
infections. In four years Sabo has grown into 
a busy center with a professional staff and 25
volunteers. HIV-positive people have started to
frequent the center and Sabo is looking into
ways of formally assisting this group as well.
The lack of knowledge about HIV and its
prevention in this society, where the topic is
considered indecent and where conforming to
behavioral norms is of utmost importance,
is worrisome. Overcoming ignorance and 
prejudice requires initiating discussions in 
the mass media about public and official 
attitudes towards HIV/AIDS. For those who
are healthy, for those who might be infected,
and for those who are already ill, it is not 
just an issue of physical health. It reflects on 
our spiritual health.
Tadjikhon Saidikramova is the chair of the
coordination council for Sabo.
Fall 2002 Harm Reduction News 14
Uzbekistan
Iskandar Ismailov of OSI-Uzbekistan (left) with Sabo staff and volunteers. Photo by Sue Simon
The sex workers that 
come to Sabo know 
about safer sex, 
contraceptives, and the 
prevention of HIV 
and sexually transmitted
infections.
A Brighter Future for Sex Workers
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Central Asia has all of the ingredients for a major HIV/AIDS epidemic:
a large population of young, sexually active injection drug users (IDUs),
epidemic levels of sexually transmitted infections (STIs), and an absence 
of drug treatment and HIV prevention programs. But the number of cases
is still small and a large outbreak is not inevitable.
Official statistics indicated virtually no HIV cases in Central Asia
before 1997 when an outbreak of several hundred HIV cases was report-
ed in the city of Temirtau, Kazakhstan, and the surrounding area. In the last
two years several other Kazakhstan cities have detected clusters of cases
and outbreaks have been noted in Kyrgystan, Uzbekistan, and Tajikistan.
The questions of how and why the HIV outbreak occurred in
Temirtau have been endlessly discussed and cannot be answered 
definitively but the region’s recent history seems to give a clue. During
Soviet times the great coal deposits in the area were exploited and 
the region became a major mining and steel production center. Temirtau
prospered as one of the largest steel centers until the Soviet Union broke
up in the early 1990s and the inefficient mill struggled through several
management changes before closing entirely.According to local observers,
the social fabric in this city of 125,000 came apart with explosive increas-
es in alcoholism and drug use, even by pre-teenaged children.
Among several probable factors in the Temirtau HIV outbreak 
are the rapid growth of drug use and the large number of young users.
The role of psychological factors such as the hopelessness triggered 
by economic upheaval leading to risky patterns of drug use and sexual
activity is more speculative.
Since HIV infection proceeds silently for several years before the
clinical illnesses known as AIDS begin to appear, there is a lag time before
the impact of new epidemics is felt. The new HIV infections that have
occurred in the last few years will begin to translate into illness and death
over the next five to 10 years. This time can be used to delay or prevent
much of the morbidity and mortality of HIV.
However, little treatment for HIV is available in Central Asia and 
this is not likely to change any time soon.The region is wracked by politi-
cal and economic turmoil and other, more immediate, health crises.
There is little time or attention for the HIV epidemic, which is in its early
stages and has not reached the critical dimensions of sub-Saharan Africa.
Further, the primary affected group—drug users and their partners—are
severely marginalized and often viewed as expendable.
The AIDS centers in Central Asia that do try to meet these 
challenges have found that comprehensive care for HIV infected patients
has four components: general health promotion; substance abuse 
treatment; opportunistic infection prevention; and anti-retroviral therapy.
Since most patients are young and free of chronic diseases, little 
general health care is needed unless STIs or complications of drug use 
are present. Substance abuse treatment, however, may be the most 
critical step in successfully dealing with HIV infection because it often
requires complex regimens with daily medications.
Most of the severe infections that complicate the advanced stages
of HIV disease (so-called “opportunistic infections”) can be prevented 
Containing the Epidemic
HIV and AIDS Treatment in Central Asia
continued on page 16
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or delayed with simple oral medication. A single daily dose of the 
antibiotic trimethoprim/sulfamethoxazole, for example, is highly effective 
in preventing two of the most common complications: pneumonia and 
toxoplasmosis. The medication is inexpensive (less than one U.S. dollar 
a month in some former Soviet countries.)
The challenge of tuberculosis (TB) deserves particular attention in
the discussion of opportunistic infections. Although HIV infection is not
needed for TB to flourish, there is a potent interaction between these 
two infections. Individuals with HIV and latent TB infection are much more
likely to have a reactivation of TB than those with TB alone.And HIV infect-
ed persons are more susceptible to primary infection with TB. These trends
become more pronounced as the degree of immunodeficiency increases
over time. Thus, the epidemic potential for the spread of TB among HIV
positive individuals in congregate settings like AIDS wards and prisons 
is great. Since TB is one of the world’s most common infections and dis-
proportionately affects impoverished people and countries it is likely to be 
the greatest cause of illness and death associated with HIV in many areas.
The Central Asian countries have higher rates of TB than Europe,
North America, or Russia. As the AIDS epidemic takes hold, TB will
become an even more formidable problem. Treatment and prevention 
of TB in HIV infected persons are potentially effective but there are 
obstacles. TB patients must adhere to and complete at least six to nine
months of treatment. Interruption of this course compromises treatment
response and also raises the chances that the infection will become drug
resistant. Spectacular mortality rates have been noted in outbreaks of
multi-drug resistant TB in prisons and AIDS facilities around the world.
AIDS care programs can help control TB by ensuring follow up 
and completion of therapy. Although the concept of directly observed
therapy for TB is generally accepted in Central Asia the patterns of care 
still heavily emphasize hospital based treatment. After being treated for 
several months in a TB hospital patients often do not complete the full 
curative regimen because there is little access to outside treatment.
AIDS treatment centers could help by ensuring that HIV-TB patients 
complete their therapy. However, the current, rigidly vertical structure of 
TB care in Central Asian countries makes such an approach problematic.
Understandably, most discussions about access to HIV care focus 
on anti-retroviral treatment because this intervention has transformed
AIDS from an inevitable killer to a manageable chronic disease in the 
West. In other parts of the world, there are increasing prospects for
patients to have access to anti-HIV treatment through the Global Fund 
to Fight AIDS, Tuberculosis and Malaria. However, drug costs remain an
enormous barrier to HIV therapy since even the cheapest generic versions
are still beyond the means of most individuals.
Policy makers, AIDS caregivers, and even harm reduction advocates
tend to exaggerate the potential difficulties of anti-HIV therapy among 
previous or current drug users. Some national AIDS programs exclude
active drug users from HIV therapy as a policy and it is often assumed 
that any drug use history means current use is likely. Just as bad, several
advocates for drug users give users the impression that the toxicity of 
the treatment and variable degree of success makes it less desirable than 
it might seem.
The plain fact is that uninterrupted access and adherence to an
appropriate HIV treatment regimen is the only requirement for success.
Active substance abuse may make this difficult for some, but not all,
patients. Ancillary efforts such as substance abuse treatment, counseling,
and treatment supervision all enhance the effectiveness of HIV treatment
in this population.
The urgency of anti-HIV therapy in areas like Central Asia may 
be hard to grasp especially compared to much larger, more advanced 
epidemics. But the potential for HIV treatment to limit the spread of the
epidemic is real—by decreasing the infectivity of those who are treated 
and by drawing many of those who fear it into preventative care. It is 
also urgent that the policy makers and caregivers begin to confront the
nuances of working with drug users rather than excluding them as a group.
Jay Dobkin is the director of the AIDS Program at Columbia-
Presbyterian Medical Center in New York.
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New HIV infections will begin 
to translate into illness and death over 
the next five to 10 years. 
In Lithuania, the results of HIV testing at the
Alytus prison by the Lithuanian AIDS Center
that found 222 of 1,900 inmates HIV infected
prompted the resignation of the head of the
prison department in June. Shortly after, about
7,000 inmates joined a hunger strike. Their
demands included treatment for HIV detainees,
cessation of the transfer of inmates from Alytus,
and better conditions in general.
In Russia, one-sixth of the registered cases of
HIV are in jail and contributing to the fastest
growing rate of HIV in the world, according to
a report by UNAIDS and the World Health
Organization. Strict drug laws are increasing the
prison population and, once there, injection
drug use and needle sharing is prevalent.
Health services are inadequate: condoms and
methadone are not allowed, HIV testing is unre-
liable and inconsistent, and many doctors
oppose harm reduction.
A report investigating overdose in
CEE/fSU suggested that fear of prison guards
leads to overdose. If a group is sharing a syringe
with enough drugs for everyone, whoever has
the syringe in hand will inject the entire amount
when a guard approaches.The report was com-
missioned by IHRD in 2001.
The 6th European Conference on Drug
and HIV/AIDS Services in Prison will be
held  in Vienna October 10-12, 2002 to 
assist the development of effective drug 
and health services in European prisons.
www.cranstoun.org.
Prison News
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by Aimuhammedova Nurnabat
I n a striking example of foresight, Turkmenistan has started an HIV prevention program in prisons. Official data indicate nocases of HIV in the prison system and HIV prevalence in 
the country is thought to be low. Yet the potential for a large 
epidemic is reflected in the high rates of drug use and sexually 
transmitted infections.
The HIV/AIDS/Drug Abuse Prevention in Prisons project, run by
the nongovernmental organization Force for Change has reached over
2,000 inmates since 2000. The project teaches prisoners how to 
protect themselves from HIV and practice safer sex by motivating
clients to change unsafe behavior.
Collaborating with the National AIDS Center and the Ministry of
Internal Affairs, Force for Change identifies leaders among 
the inmates and works with prison personnel to gain their cooperation.
The leaders are trained to carry out peer support education. Special
information materials for the project have been developed, tested,
and produced. Such information and counseling have proven particular-
ly successful in gaining clients’ trust. Methadone replacement therapy 
is illegal and the possibilities for needle and syringe exchange are 
being studied by Force for Change.Yet some harm reduction practices
such as disinfectants in prison dormitories and condom distribution 
are used in the project.
Force for Change chose to start the project, which is supported 
by IHRD, in the Akhalsky prison system since its three penitentiaries 
are located within one city. The work will continue here while 
we expand the project to other prisons in the country.
Aimuhammedova Nurnabat is director of the NGO Force for Change
in Ashgabat,Turkmenistan.
Turkmen Prisons
Preventing HIV Before It Starts
H eroin was seized for the first time in Uralsk, the regional center for western Kazakhstan close to Russia’s border, in1998. Since then, law enforcement agents have been regular-
ly detaining drug users and heroin dealers. Drugs come into the city
through Russia from the Chechen Republic and from the southern parts
of Kazakhstan, where it is trafficked from Tajikistan and Kyrgyzstan.
By July 2002 the local narcological hospital had registered 1,211
“drug addicts.” The city has registered 112 people living with HIV.
In response to the HIV epidemic, IHRD technical advisor Nurlan
Disonov set up a nongovernmental organization needle and syringe
exchange called Movement.There is some uncertainty in the public mind
in Uralsk about the legality of needle exchange. It is widely believed that 
drug users are criminals and a threat to public order because they 
use drugs in the backyards and doorways of houses and sometimes 
commit crimes.
On an IHRD study tour for policemen last year, I visited a 
harm reduction project in Poland. The project was interesting and 
novel to me, especially the way it gave hope and optimism to drug 
addicts. What I saw in Poland persuaded me that the state is not the 
only entity that can deal with the drug problem.
Many drug users are afraid of the police and law enforcement 
officials because current legislation mandates that we charge them with 
illicit drug trafficking. And most policemen are in favor of isolating and 
incarcerating drug users. If they knew more about harm reduction they
would understand that it enables drug users to stop violating the law 
and return to society as useful people.
Toulesh Ergaliev is lieutenant colonel at the Department of Drug
Control, Interior Affairs, Region of Western Kazakhstan.
Given a Chance, Police Favor Harm Reduction
Prison staff being trained in HIV prevention in Turkmenistan. Photo © 2002 Force for Change
by Toulesh Ergaliev
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Gay Men’s Health Crisis (GMHC) and
IHRD have announced an HIV Advocacy
Fellowship program that will bring advocates
from Eastern Europe and Central Asia to
GMHC’s New York headquarters for an
intensive six-week program in late 2002.
Fellows will learn the skills needed to change
the HIV/AIDS policies of governments,
employers, and private institutions, such as
pharmaceutical companies, so that they best
serve the needs of people living with HIV.
The Reference Group on HIV/AIDS
Prevention and Care Among Injecting Drug
Users will advise the UNAIDS secretariat
and its six U.N. co-sponsors on effective
HIV/AIDS prevention and care among IDUs.
The group, established and supported by
UNDCP, WHO, and UNAIDS, invited Kasia
Malinowska-Sempruch to participate and
held its first meeting in Vienna in July.
Pre- and post-test HIV counseling
is the subject of the newest IHRD training,
which covers counseling, care, and support,
discussion of case studies, and working out
the methods of providing assistance. The
first training session was held in Poland 
in September and attended by 20 IHRD
grantees.
IHRD’s technical advisors met in July 
in St. Petersburg to discuss key areas of
IHRD work: the shift to policy work; the role
of harm reduction projects in local and
regional advocacy and policy efforts; data
collection and monitoring; substitution treat-
ment; care and support for HIV infected
IDUs; and the role of TAs in IHRD’s long
term strategy development.
IHRD’s advisory group met in June in
New York to discuss IHRD’s future develop-
ment, including the exploration of policy
development in sister countries such as Iran
and China.
The South Eastern Europe (SEE)
Conference on HIV/AIDS met in Romania
in June to discuss implementing the Global
Declaration of Commitment on HIV/AIDS.
Conference members agreed to implement
the goals of the declaration and to scale 
up national responses to HIV/AIDS. Monica
Ciupagea made a presentation on IHRD’s
work with IDUs in SEE.
Concern over Iran’s estimated 1.5
million opium addicts and .5 million
heroin users prompted Iran to invite Bob
Newman of the U.S., Marek Beniowski of
Poland, and Alex Wodak of Australia to run
a workshop for over 100 colleagues from
the private sector, academia, and govern-
ment ministries. The three-day intensive 
discussion in June focused on how addiction
treatment should be introduced in Iran.
“The Iranians are clearly committed to 
a major initiative aimed not at creating a 
cute little pilot but addressing the problem
on a meaningful scale,” said Newman.
“I have never before encountered such
unequivocal dedication to provide help for
those in need.”
Mandatory HIV testing of high risk
groups has been abolished in Kazakhstan,
according to the Kazakh newspaper Novoye
Pokoleniye. Only blood donors will undergo
obligatory examination in a country which
had in May this year 2,780 people registered
with HIV. The new rules were recom-
mended by Western human rights organiza-
tions which criticized the mandatory testing
as a violation of human rights.
HIV prevention measures have success-
fully reduced the growth of HIV in Latvia,
said the Welfare Ministry in July. The Baltic
News Service reports that eight new 
needle and syringe exchange points will 
be set up throughout the country.
Two-thirds of the military conscripts
in Russia’s Chelyabinsk region were found
unfit for service in the spring of 2002,
largely for health reasons. According to a
report by ITAR-TASS, 215 young men were
HIV infected and 217 were “drug addicts.”
An additional 6,000 men of call-up age 
in the region have criminal records and 
cannot be drafted.
The HIV/AIDS epidemic is a U.S.
foreign policy imperative, declared the U.S.
Department of International Health and
Science in August. A representative of 
the department also noted the urgency 
of preventive measures in Russia, China,
and India, according to AIDS Policy and Law.
John Ranard, a social documentary 
photographer who has provided stunning
photographs of IDUs to OSI/IHRD now has
a website: www.johnranard.com.
Central and Eastern Europe and the former
Soviet Union made an impression at the
International AIDS Conference held this
year in Barcelona in July. A satellite meeting
run by the Eastern European Harm
Reduction Network was the first event ever
at the conference to focus on the region.
On the strength of his appearance at 
the satellite, Stas, a Russian living with HIV,
was invited onto the stage at the closing 
plenary with Nelson Mandela and Bill
Clinton. Kasia Malinowska-Sempruch gave 
a plenary speech to thousands of people
that was widely quoted in the international
press. It was the first time at the confer-
ence’s plenary that a speech focused on 
the region or on drug use issues.
NewsBriefs
XIV International AIDS Conference
IHRD TA Marek Beniowski at the satellite.
With pain in our hearts and utter sadness we wish to inform you that
Marek Kotanski passed away as a result of injuries suffered in a car 
accident on August 19. He was returning from a meeting in one of his
houses for homeless people.
Thousands of people in Poland and many countries of the
world—the addicted, sick, lonely, homeless, youth, elderly, parents,
and teachers—are in profound mourning. Marek was not only the
founder of the MONAR Association and its only leader, full of 
incredible charisma and stamina. He was also fully devoted to others.
His motto was “Give yourself to others.” He always found time for
those in need. One could always count on him. Everybody he met
regarded him as a genuine friend.
Marek created MONAR, the largest organization in this part 
of Europe for the prevention and treatment of addictions. He was
always searching for new solutions to social problems. Nobody 
could keep up with his ideas. A visionary and an idealist. A keen 
psychologist-therapist and unconventional tutor. His intuition and
courage in the search for new, more effective forms of help for 
people in need often became a challenge to others. His actions, often
controversial, would ultimately turn out to be innovative and ahead 
of their time. Lack of funds could never stop his new initiatives.
As a member of official committees and bodies he always spoke the
truth openly. He broke stereotypes and provocatively defended the 
dignity and rights of women and men hurt by destiny and thrown to 
the social margins.
He used to warn all of us to beware of commercialization and 
the loss of spirituality. He taught us that it is necessary to be, not to have.
He believed that one could “see only with the heart.” He inspired mil-
lions of people with his ideas. He always maintained personal relations
with all of the employees of MONAR. He loved discussions with friends,
heated arguments, and father’s lessons. He often asked us:“Do you love
me?” We do love...you don’t even know how much we do, Marek! 
May we have the strength and endurance to continue his deeds.
Marek will stay in our hearts forever.
Marek Kotanski
1942-2002
F or 35 years Marek Kotanski worked for the homeless, sick, and people addicted to drugs. An innovative, tireless problem solver, he founded 110 homes all over Poland and abroad. Many civil society organizations and foundations havetheir roots in the MONAR Association, the comprehensive system of rehabilitation and prevention of drug addiction 
that he set up in 1981. MONAR has founded several rehabilitation centers in Russia and Ukraine and served as a model for 
organizations in Central and Eastern Europe and Asia. Marek Kotanski was nominated this year for the U.N.Vienna Civil Society
Award in recognition of his outstanding contribution to counteracting drug abuse, crime, and terrorism.
He defended the dignity and rights of women and men hurt by destiny and thrown to the social margins.
A letter from all the people of MONAR
Marek Kotanski (right) with MONAR outreach worker Dariusz Denis talking with needle exchange clients in Planta Park, Krakow. Photo © 2002 MONAR
Country TAs
Albania
Grzegorz Wodowski
MONAR Krakow, Poland
Azerbaijan and Belarus
Aleksandr Slatvickij
Klaipeda Addiction 
Treatment Center, Lithuania
Bulgaria
Elena Yankova, Initiative 
for Health Foundation, Bulgaria
Central Asia
Askar Akhmedov
UNDP Joint Project on HIV,
Uzbekistan
Maram Azizmamadov
Volunteer Association,Tajikistan
Natalya Babina, Pavlodar Regional
AIDS Center, Kazakhstan
Batesh Bapenova, Aqmola
Regional AIDS Center, Kazakhstan
Nurlan Dissonov,
Public Foundation 
“Dvizheniye,” Kazakhstan
Konstantin Emelyanov
Psychotherapy Center 
“Imaton,” Kazakhstan
Yevgeny Ten
NGO “Socium,” Kyrgyzstan
Marek Zygadlo, Krakow
Association for Drug Use, Poland
Croatia
Grzegorz Wodowski
MONAR Krakow, Poland
Macedonia
Zahari Nikolov, Initiative for
Health Foundation, Bulgaria
Romania
Dan Bigg 
Chicago Recovery Alliance, U.S.A.
Russia
Asya Bidordinova
AIDS Foundation East West, Russia
Olga Blinova
Anti AIDS Center NGO, Russia
Alec Khachatrian,
UNAIDS Moscow, Russia
Vladimir Musatov
Médecines du Monde, Russia
Zahari Nikolov, Initiative for
Health Foundation, Bulgaria
Sergey Oleynik
Anti-AIDS Foundation, Russia
Evgeny Petunin
AIDS Stop Foundation, Russia
Iraida Sivacheva, Pskkovian 
Anti-Aids Initiative, Russia
Alexander Tsekhanovich
Médecins du Monde, Russia
Tatiana Vanenkova, Nikolaev
Charity Fund “Unitus,” Ukraine
Igor Vassilenko, Public 
Foundation,“Help,” Kazakhstan
Slovak Republic
Katarina Jiresova 
Odyseus, Slovak Republic
Ukraine
Sergey Kostin
The Way Home, Ukraine
Andrey Protopopov
Charitable Anti AIDS Fund, Ukraine
Anatoly Yakobchuk
Zhytomir Regional Charitable
Fund, Ukraine
Issue TAs
Methadone
Emilis Subata 
Vilnius Substance Abuse 
Treatment Center, Lithuania
Marek Beniowski
Center for AIDS Diagnostics 
and Therapy for Katowice 
District, Poland
Albania
Valdete Sala and Ledia Curri
Open Society Fund– Albania
soros-al@osfa.soros.al
Armenia
Anahit Papikyan, Open Society
Institute– Armenia, panaida@osi.am
Azerbaijan
Layla Imanova Open Society 
Institute – Azerbaijan
limanova@osi-az.org
Belarus
Valentina Stalyho, United Nations 
Development Program
valentina.stalyho@undp.org
Nastia Kamlik, Positive Movement
kamnast@tut.by
Bulgaria
Emilia Tontcheva
Open Society Foundation –Sofia
etoncheva@osf.bg
Croatia
Natasa Janev
Open Society Institute –Croatia
njanev@soros.hr
Czech Republic
Olga Gajicova
Open Society Fund–Prague
olga.gajicova@osf.cz
Estonia
Mall Hellam
Open Estonia Foundation
mall@oef.org.ee
Georgia
Lasha Zaalishvili
Open Society Georgia Foundation
lasha@osgf.ge
Hungary
Katalin Szoke, Soros Foundation
–Hungary, szoke@soros.hu
Kazakhstan
Valeria Gourevich
Soros Foundation–Kazakhstan
vgourev@soros.kz
Kyrgyzstan
Elvira Muratalieva
Soros Foundation–Kyrgyzstan
elvira@soros.kg
Latvia
Ingrida Skuja, Soros Foundation–Latvia
ingrida@sfl.lv
Lithuania
Virginija Ambrazeviciene 
Open Society Fund – Lithuania
virginij@osf.lt
Macedonia
Vera Dimitrievska
Open Society Institute–Macedonia
vdimit@soros.org.mk
Moldova
Viorel Soltan
Soros Foundation–Moldova
vsoltan@soros.md
Poland
Aleksandra Duda.
United Nations Development Program
aleksandra.duda@undp.org
Romania
Ioana Daramus
Center for Health Policies and Services
idaramus@buc.osf.ro
Russia
Alexei Bobrik and 
Vitaly Zhumagaliev
Open Society Institute– Russia
zhuma@osi.ru
Slovak Republic
Tanja Rajniakova
Open Society Fund–Bratislava
tana@osf.sk
Tajikistan
Zarina Abdullaeva
Open Society Institute–Tajikistan
azarina@tajik.net
Turkmenistan
Rustam Alymov and 
Galina Karmanova
United Nations Development Program
rustam.alymov@untuk.org
Ukraine
Denis Poltavets
International Renaissance
Foundation–Kyiv
poltavets@irf.kiev.ua
Uzbekistan
Iskandar Ismailov
Open Society Institute–Uzbekistan
iskandar@osi.freenet.uz
Upcoming Events
Contacts
IHRD Coordinators IHRD Technical Advisors
November 22-24
Canadian Harm
Reduction 
Conference
Toronto, Canada
www.harmreduction2002.ca
November 27-29
Search for Quality 
in School Based 
Drug Prevention
Hamburg, Germany
www.school-and-drugs.org
December 1-4
4th National 
Harm Reduction
Conference
Seattle,Washington, USA
www.harmreduction.org
December 8-11
North American 
AIDS Treatment 
Action Forum
New Orleans, Louisiana, USA
www.nmac.org
April 6-10, 2003
14th International 
Conference on the Reduction
of Drug Related Harm
Chiangmai,Thailand 
www.ihrc2003.net 
